Kneat.com Inc (KSI) - Total Liabilities
Based on the latest financial reports, Kneat.com Inc (KSI) has total liabilities worth CA$65.51 Million CAD (≈ $47.39 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Kneat.com Inc to assess how effectively this company generates cash.
Kneat.com Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Kneat.com Inc's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Kneat.com Inc to evaluate the company's liquid asset resilience ratio.
Kneat.com Inc Competitors by Total Liabilities
The table below lists competitors of Kneat.com Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sichuan Dowell Science and Technology Inc
SHE:300535
|
China | CN¥435.91 Million |
|
Air Asia Co Ltd
TW:2630
|
Taiwan | NT$2.77 Billion |
|
Sabvest Capital Ltd
JSE:SBP
|
South Africa | ZAC2.17 Million |
|
Shoper S.A.
WAR:SHO
|
Poland | zł64.77 Million |
|
Easy Trip Planners Limited
NSE:EASEMYTRIP
|
India | Rs4.04 Billion |
|
Duopharma Biotech Bhd
KLSE:7148
|
Malaysia | RM690.68 Million |
|
Sunplus Innovation Technology Inc.
TWO:5236
|
Taiwan | NT$460.66 Million |
|
Koramco Energy Plus Reit Co Ltd
KO:357120
|
Korea | ₩781.19 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Kneat.com Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Kneat.com Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kneat.com Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kneat.com Inc (2013–2024)
The table below shows the annual total liabilities of Kneat.com Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$59.51 Million ≈ $43.05 Million |
+19.65% |
| 2023-12-31 | CA$49.73 Million ≈ $35.98 Million |
+103.60% |
| 2022-12-31 | CA$24.43 Million ≈ $17.67 Million |
+42.89% |
| 2021-12-31 | CA$17.09 Million ≈ $12.37 Million |
+17.18% |
| 2020-12-31 | CA$14.59 Million ≈ $10.55 Million |
+320.65% |
| 2019-12-31 | CA$3.47 Million ≈ $2.51 Million |
+37.54% |
| 2018-12-31 | CA$2.52 Million ≈ $1.82 Million |
+634.81% |
| 2017-12-31 | CA$343.14K ≈ $248.22K |
-84.97% |
| 2016-12-31 | CA$2.28 Million ≈ $1.65 Million |
+287.09% |
| 2015-12-31 | CA$589.96K ≈ $426.77K |
+270.96% |
| 2014-12-31 | CA$159.03K ≈ $115.04K |
+10160.32% |
| 2013-12-31 | CA$1.55K ≈ $1.12K |
-- |
About Kneat.com Inc
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufa… Read more